Testing effectiveness (Phase 2)Not Yet RecruitingNCT07614412
What this trial is testing
SHIELD-T1D: Shingrix and GLP-1 Agonist for Beta-Cell Preservation in Recent-Onset Type 1 Diabetes.
Who this might be right for
Type 1 Diabetes Mellitus
Ministry of Health, Saudi Arabia 240